Skip to Main Content

Author Details

Hein Than
Singapore General Hospital
2012
22
11
PMIDPaper TitleJournal TitlePublished Year
36715661Favorable outcomes of COVID-19 in vaccinated hematopoietic stem cell transplant recipients: A single-center experience.Transpl Infect Dis2023
37259074A cost-effectiveness analysis of ruxolitinib versus best alternative therapy for patients with steroid-refractory chronic graft-versus-host disease aged⿿>⿿12 years in Singapore.Cost Eff Resour Alloc2023
37165850A proposed predictive mathematical model for efficient T-cell collection by leukapheresis for manufacturing chimeric antigen receptor T cells.Haematologica2023
36857629A single-cell atlas identifies pretreatment features of primary imatinib resistance in chronic myeloid leukemia.Blood2023
36856978Conjunctival T Cell Profile in Allogeneic Hematopoietic Stem Cell Transplant Patients after Instilling Topical Cyclosporine-A 0.1% Cationic Emulsion.Ophthalmol Ther2023
34027418SIRT5 IS A DRUGGABLE METABOLIC VULNERABILITY IN ACUTE MYELOID LEUKEMIA.Blood Cancer Discov2021
32091287Mobilization kinetics of peripheral blood stem cells with rescue plerixafor - real-world experience from a single center.Leuk Lymphoma2020
32051529SRSF1 mediates cytokine-induced impaired imatinib sensitivity in chronic myeloid leukemia.Leukemia2020
31980730Coordinated inhibition of nuclear export and Bcr-Abl1 selectively targets chronic myeloid leukemia stem cells.Leukemia2020
30563936Nuclear-Cytoplasmic Transport Is a Therapeutic Target in Myelofibrosis.Clin Cancer Res2019
31648319The transcriptome of CMML monocytes is highly inflammatory and reflects leukemia-specific and age-related alterations.Blood Adv2019
29916288BIM deletion polymorphism profiling complements prognostic values of risk scores in imatinib-treated Asian chronic myeloid leukemia patients.Leuk Lymphoma2019
31543464Combining the Allosteric Inhibitor Asciminib with Ponatinib Suppresses Emergence of and Restores Efficacy against Highly Resistant BCR-ABL1 Mutants.Cancer Cell2019
31366621Genomic landscape of neutrophilic leukemias of ambiguous diagnosis.Blood2019
31276961Lysosome Inhibition by Mefloquine Preferentially Enhances the Cytotoxic Effects of Tyrosine Kinase Inhibitors in Blast Phase Chronic Myeloid Leukemia.Transl Oncol2019
29588547Ongoing clonal evolution in chronic myelomonocytic leukemia on hypomethylating agents: a computational perspective.Leukemia2018
27822611Rivaroxaban for heparin-induced thrombocytopenia: adding to the evidence.Ann Hematol2017
24974053First experiences with the use of rivaroxaban in the treatment of heparin-induced thrombocytopenia.Thromb Res2015
26378050Pyrvinium selectively targets blast phase-chronic myeloid leukemia through inhibition of mitochondrial respiration.Oncotarget2015
26058545A comprehensive study of current haemophilia care and outcomes in Singapore.Haemophilia2015
25688138Clinical utility of anti-Xa monitoring and differential sensitivity of prothrombin time assays: an illustrated case report.J Clin Pathol2015
22426421A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer.Nat Med2012
  • 1 - 22 of 22

Recommended Authors

Jennifer N Saultz
Knight Cancer Institute, Oregon Health and Science University
Career Start Year 2012
Number of shared co-authors 22
Andy Kaempf
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2011
Number of shared co-authors 26
Lina Benajiba
Universite de Paris, Inserm CIC 1427
Career Start Year 2009
Number of shared co-authors 2
Uma Borate
The Ohio State University
Career Start Year 2008
Number of shared co-authors 28
Friedrich St??lzel
University Hospital TU Dresden
Career Start Year 2008
Number of shared co-authors 4
Paulo Vidal Campregher
Hospital Israelita Albert Einstein
Career Start Year 2007
Number of shared co-authors 0
Courtney D DiNardo
UT MD Anderson Cancer Center
Career Start Year 2007
Number of shared co-authors 9
Anupriya Agarwal
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2006
Number of shared co-authors 38
Thomas Cluzeau
Universite Nice Cote d'azur, CHU de Nice
Career Start Year 2005
Number of shared co-authors 1
Naseema Gangat
Mayo Clinic
Career Start Year 2004
Number of shared co-authors 3
Tara L Lin
University of Kansas Medical Center
Career Start Year 2004
Number of shared co-authors 25
Ronan Swords
Oregon Health and Science University
Career Start Year 2004
Number of shared co-authors 28
Jean-Baptiste Micol
INSERM U7, Universite Paris-Saclay
Career Start Year 2004
Number of shared co-authors 2
Christopher R Cogle
College of Medicine, University of Florida
Career Start Year 2003
Number of shared co-authors 25
Thomas Ernst
Universitatsklinikum Jena
Career Start Year 2002
Number of shared co-authors 2
Christoph R??llig
Hopp Children's Cancer Center (KiTZ)
Career Start Year 2000
Number of shared co-authors 6
Emmanuel Raffoux
Universite Paris Diderot
Career Start Year 1998
Number of shared co-authors 3
Elie Traer
Oregon Health & Science University
Career Start Year 1998
Number of shared co-authors 31
Farhad Ravandi
University of Texas M.D. Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 21
Guillermo Garcia-Manero
MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 22
Nikolas von Bubnoff
University Hospital of Schleswig-Holstein
Career Start Year 1997
Number of shared co-authors 4
Thoralf Lange
Hospital Weissenfels
Career Start Year 1994
Number of shared co-authors 14
Michael Heuser
Hannover Medical School
Career Start Year 1993
Number of shared co-authors 7
Michael W Becker
James P. Wilmot Cancer Institute, University of Rochester Medical Center Rochester
Career Start Year 1992
Number of shared co-authors 5
Gautam Borthakur
MD Anderson Cancer Center
Career Start Year 1992
Number of shared co-authors 21
Jorge Cortes
Georgia Cancer Center
Career Start Year 1991
Number of shared co-authors 33
Peter Westervelt
Washington University School of Medicine
Career Start Year 1990
Number of shared co-authors 7
Jerald P Radich
Fred Hutchinson Cancer Center
Career Start Year 1989
Number of shared co-authors 25
Martin S Tallman
Memorial Sloan-Kettering Cancer Center
Career Start Year 1982
Number of shared co-authors 11
Hagop Kantarjian
The University of Texas MD Anderson Cancer Center
Career Start Year 1982
Number of shared co-authors 32

Collaborators

Michael W Deininger
University of Utah Huntsman Cancer Institute
Co-authored papers 7
Dongqing Yan
Inner Mongolia University
Co-authored papers 6
Anthony D Pomicter
Huntsman Cancer Institute, University of Utah
Co-authored papers 6
Thomas O'Hare
Huntsman Cancer Institute, University of Utah
Co-authored papers 5
Phillip M Clair
Huntsman Cancer Institute, The University of Utah
Co-authored papers 4
Jamshid S Khorashad
Institute of Cancer Research
Co-authored papers 4
Anna Senina
Huntsman Cancer Institute, The University of Utah
Co-authored papers 4
Jonathan M Ahmann
Huntsman Cancer Institute, The University of Utah
Co-authored papers 3
Brian J Druker
Oregon Health & Science University
Co-authored papers 2
Anna M Eiring
Texas Tech University Health Sciences Center at El Paso
Co-authored papers 2
Jeffrey W Tyner
Oregon Health & Science University School of Medicine
Co-authored papers 2
Christopher A Eide
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Anca Franzini
University of Utah
Co-authored papers 2
Srinivas K Tantravahi
Huntsman Cancer Institute at the University of Utah.
Co-authored papers 2
Hannah M Redwine
Huntsman Cancer Institute, The University of Utah
Co-authored papers 2
Matthew S Zabriskie
University of Utah
Co-authored papers 2
Markus M N??then
Institute of Human Genetics, University Hospital Bonn
Co-authored papers 1
Haijiao Zhang
Oregon Health & Science University, Knight Cancer Institute
Co-authored papers 1
Hiroyuki Mano
Co-authored papers 1
Tien Yin Wong
Tsinghua University
Co-authored papers 1
Robert P Searles
Oregon Health & Science University
Co-authored papers 1
Daniel A Pollyea
University of Colorado Division of Hematology
Co-authored papers 1
Jason Gotlib
Stanford University School of Medicine
Co-authored papers 1
Daniel J DeAngelo
Dana-Farber Cancer Institute
Co-authored papers 1
Niranjan Nagarajan
Co-authored papers 1
Chenwei Lin
Clinical Research Division, Fred Hutchinson Cancer Center
Co-authored papers 1
Shannon K McWeeney
Oregon Health & Science University, University of California Berkeley
Co-authored papers 1
Fei Yao
Co-authored papers 1
Robert H Collins
University of Texas Southwestern Medical Center
Co-authored papers 1
Shyam Prabhakar
Genome Institute of Singapore (GIS)
Co-authored papers 1
Release 1.2